Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. Viking has lost more ...

Fintel reports that on April 8, 2025, Goldman Sachs initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...

Viking Therapeutics (VKTX) stock receives a Neutral rating at Goldman Sachs due to intense competition in its targeted ...

Goldman Sachs analyst Richard Law initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $30 price target The company’s ...

Insiders have been trading these 5 stocks: (($GME)), (($DELL)), (($ZS)), (($SLB)) and (($VKTX)). Here is a breakdown of their ...